Moody’s affirms Aspirus Wausau Hospital’s ‘A1’ rating

Moody’s Investors Service affirmed the “A1” rating on Aspirus Wausau (Wis.) Hospital’s $170 million of rated revenue bonds.

Advertisement

The rating affirmation is based on Aspirus’ solid operating profitability, healthy liquidity position and strong leverage measures. The hospital also faces several challenges, including a competitive market.

The outlook is stable, reflecting Moody’s Investors Service’s expectation that Aspirus will continue to generate solid margins.

More articles on healthcare finance:
How productivity improvements could help healthcare lower prices
VSS Medical Technologies expands with Legato acquisition: 5 things to know
Capital One launches new unitranche loan program

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.